Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Repare Therapeutics Inc. | RPTX | $2.65 Jan 28, 2026 | $114.24M | — | |
| BGM Group Ltd. | BGM | $0.29 | $114.18M | — | |
| ProMIS Neurosciences, Inc. | PMN | $12.60 | $112.99M | — | |
| Definitive Healthcare Corp. | DH | $1.05 | $112.08M | — | |
| Coya Therapeutics, Inc. | COYA | $4.76 | $111.66M | — | |
| Fractyl Health, Inc. | GUTS | $0.70 | $110.88M | — | |
| Genelux Corporation | GNLX | $2.44 | $110.40M | — | |
| PolyPid Ltd. | PYPD | $5.39 | $109.48M | — | |
| Seer, Inc. | SEER | $1.95 | $107.98M | — | |
| RenovoRx, Inc. | RNXT | $2.39 | $107.86M | — | |
| Oncolytics Biotech Inc. | ONCY | $0.84 | $107.52M | — | |
| LENSAR, Inc. | LNSR | $8.58 | $105.41M | 42.9 | — |
| Anixa Biosciences, Inc. | ANIX | $3.07 | $104.45M | — | |
| Coeptis Therapeutics Holdings Inc | COEP | $16.40 Apr 24, 2026 | $102.06M | — | |
| Cumberland Pharmaceuticals Inc. | CPIX | $6.79 | $101.74M | — | |
| Polaryx Therapeutics, Inc. | PLYX | $2.00 | $99.69M | — | |
| Atara Biotherapeutics, Inc. | ATRA | $9.76 | $97.97M | — | |
| Cognition Therapeutics, Inc. | CGTX | $1.03 | $97.95M | — | |
| Park Dental Partners, Inc. | PARK | $20.43 | $97.15M | — | |
| Microbot Medical Inc. | MBOT | $1.44 | $96.72M | — | |
| Pulmonx Corporation | LUNG | $2.21 | $94.92M | — | |
| CareCloud, Inc. | CCLD | $2.23 | $94.76M | 31.9 | — |
| Pelthos Therapeutics Inc. | PTHS | $24.35 | $93.22M | — | |
| Accendra Health, Inc. | ACH | $1.21 | $93.05M | — | |
| Kalaris Therapeutics, Inc. | KLRS | $3.90 | $92.84M | — | |
| Acrivon Therapeutics, Inc. | ACRV | $2.13 | $91.28M | — | |
| Verrica Pharmaceuticals Inc. | VRCA | $5.30 | $91.05M | — | |
| Citius Oncology, Inc. | CTOR | $0.86 | $90.95M | — | |
| Fortress Biotech, Inc. | FBIO | $2.72 | $90.71M | 1.0 | — |
| ImmuCell Corporation | ICCC | $9.90 | $89.91M | 141.4 | — |
| Rallybio Corporation | RLYB | $16.93 | $89.88M | 2.1 | — |
| Adicet Bio, Inc. | ACET | $9.59 | $89.78M | — | |
| Aldeyra Therapeutics, Inc. | ALDX | $1.48 | $89.28M | — | |
| OS Therapies Incorporated | OSTX | $1.88 | $87.37M | — | |
| Hyperfine, Inc. | HYPR | $0.81 | $86.25M | — | |
| Gossamer Bio, Inc. | GOSS | $0.18 | $85.69M | — | |
| Cardiff Oncology, Inc. | CRDF | $1.09 | $84.80M | — | |
| iBio, Inc. | IBIO | $1.31 | $84.24M | — | |
| electroCore, Inc. | ECOR | $9.21 | $83.04M | — | |
| Alterity Therapeutics Limited | ATHE | $4.54 | $82.67M | — | |
| OKYO Pharma Limited | OKYO | $1.57 | $82.39M | — | |
| InterCure Ltd. | INCR | $5.42 | $81.32M | — | |
| CVRx, Inc. | CVRX | $3.05 | $81.26M | — | |
| Yarrow Bioscience Inc | YARW | $30.21 | $80.65M | — | — |
| MAIA Biotechnology, Inc. | MAIA | $1.32 | $80.30M | — | |
| MediciNova, Inc. | MNOV | $1.63 | $80.23M | — | |
| Telomir Pharmaceuticals, Inc. | TELO | $1.16 | $79.78M | — | |
| Sera Prognostics, Inc. | SERA | $2.02 | $79.69M | — | |
| Apollomics, Inc. | APLM | $27.50 | $79.63M | — | |
| Sangamo Therapeutics, Inc. | SGMO | $0.19 May 26, 2026 | $78.71M | — |
Repare Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $114.24M
- P/E
- unprofitable
BGM Group Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $114.18M
- P/E
- unprofitable
ProMIS Neurosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $112.99M
- P/E
- unprofitable
Definitive Healthcare Corp.
Healthcare / Health Information Services
- Market Cap
- $112.08M
- P/E
- unprofitable
Coya Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $111.66M
- P/E
- unprofitable
Fractyl Health, Inc.
Healthcare / Biotechnology
- Market Cap
- $110.88M
- P/E
- unprofitable
Genelux Corporation
Healthcare / Biotechnology
- Market Cap
- $110.40M
- P/E
- unprofitable
PolyPid Ltd.
Healthcare / Biotechnology
- Market Cap
- $109.48M
- P/E
- unprofitable
Seer, Inc.
Healthcare / Biotechnology
- Market Cap
- $107.98M
- P/E
- unprofitable
RenovoRx, Inc.
Healthcare / Biotechnology
- Market Cap
- $107.86M
- P/E
- unprofitable
Oncolytics Biotech Inc.
Healthcare / Biotechnology
- Market Cap
- $107.52M
- P/E
- unprofitable
LENSAR, Inc.
Healthcare / Medical Devices
- Market Cap
- $105.41M
- P/E
- 42.9
Anixa Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $104.45M
- P/E
- unprofitable
Coeptis Therapeutics Holdings Inc
Healthcare / Biotechnology
- Market Cap
- $102.06M
- P/E
- unprofitable
Cumberland Pharmaceuticals Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $101.74M
- P/E
- unprofitable
Polaryx Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $99.69M
- P/E
- unprofitable
Atara Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $97.97M
- P/E
- unprofitable
Cognition Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $97.95M
- P/E
- unprofitable
Park Dental Partners, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $97.15M
- P/E
- unprofitable
Microbot Medical Inc.
Healthcare / Medical Devices
- Market Cap
- $96.72M
- P/E
- unprofitable
Pulmonx Corporation
Healthcare / Medical Devices
- Market Cap
- $94.92M
- P/E
- unprofitable
CareCloud, Inc.
Healthcare / Health Information Services
- Market Cap
- $94.76M
- P/E
- 31.9
Pelthos Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $93.22M
- P/E
- unprofitable
Accendra Health, Inc.
Healthcare / Medical Distribution
- Market Cap
- $93.05M
- P/E
- unprofitable
Kalaris Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $92.84M
- P/E
- unprofitable
Acrivon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $91.28M
- P/E
- unprofitable
Verrica Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $91.05M
- P/E
- unprofitable
Citius Oncology, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $90.95M
- P/E
- unprofitable
Fortress Biotech, Inc.
Healthcare / Biotechnology
- Market Cap
- $90.71M
- P/E
- 1.0
ImmuCell Corporation
Healthcare / Biotechnology
- Market Cap
- $89.91M
- P/E
- 141.4
Rallybio Corporation
Healthcare / Biotechnology
- Market Cap
- $89.88M
- P/E
- 2.1
Adicet Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $89.78M
- P/E
- unprofitable
Aldeyra Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $89.28M
- P/E
- unprofitable
OS Therapies Incorporated
Healthcare / Biotechnology
- Market Cap
- $87.37M
- P/E
- unprofitable
Hyperfine, Inc.
Healthcare / Medical Devices
- Market Cap
- $86.25M
- P/E
- unprofitable
Gossamer Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $85.69M
- P/E
- unprofitable
Cardiff Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $84.80M
- P/E
- unprofitable
iBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $84.24M
- P/E
- unprofitable
electroCore, Inc.
Healthcare / Medical Devices
- Market Cap
- $83.04M
- P/E
- unprofitable
Alterity Therapeutics Limited
Healthcare / Biotechnology
- Market Cap
- $82.67M
- P/E
- unprofitable
OKYO Pharma Limited
Healthcare / Biotechnology
- Market Cap
- $82.39M
- P/E
- unprofitable
InterCure Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $81.32M
- P/E
- unprofitable
CVRx, Inc.
Healthcare / Medical Devices
- Market Cap
- $81.26M
- P/E
- unprofitable
Yarrow Bioscience Inc
Healthcare / Biotechnology
- Market Cap
- $80.65M
MAIA Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $80.30M
- P/E
- unprofitable
MediciNova, Inc.
Healthcare / Biotechnology
- Market Cap
- $80.23M
- P/E
- unprofitable
Telomir Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $79.78M
- P/E
- unprofitable
Sera Prognostics, Inc.
Healthcare / Medical Devices
- Market Cap
- $79.69M
- P/E
- unprofitable
Apollomics, Inc.
Healthcare / Biotechnology
- Market Cap
- $79.63M
- P/E
- unprofitable
Sangamo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $78.71M
- P/E
- unprofitable
Showing 751–800 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.